Skip to content

Vision Screening Study for College Students at Nankai University

Vision Screening Study for College Students at Nankai University

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05925153
Enrollment
8500
Registered
2023-06-29
Start date
2022-09-01
Completion date
2022-10-31
Last updated
2023-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma

Brief summary

The prevalence of myopia among high school students in China is as high as 80%-90%. For college students with longer years of education, the majority of myopia and the factors influencing the prevalence of high myopia should be better understood for timely prevention and treatment. This study aims to investigate the prevalence of myopia and education-related influencing factors among college students at Nankai University.

Interventions

OTHERNo intervention

No intervention

Sponsors

Tianjin Eye Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to 30 Years

Inclusion criteria

* All 1st year students

Exclusion criteria

* No eye diseases such as cataracts, glaucoma,keratoconus, etc. * No psychiatric disorders * Astigmatism ≤ -6.00D

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of myopiaOne day measurementMyopia was defined as an equivalent spherical refraction ≤ -0.50D in either eye
Prevalence of high myopiaOne day measurementHigh myopia was defined as an equivalent spherical refraction ≤ -6.00D in either eye

Secondary

MeasureTime frameDescription
Blood pressureOne day measurementVenous blood pressure was measured using a sphygmomanometer, and systolic and diastolic blood pressure results were recorded.
PulseOne day measurementMeasure the number of pulses in the quiet state and record the number of beats per minute.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026